Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 03/20/2026 | PUT | $920.00 | 1,144 | +696 | +155.36% |
| 02/13/2026 | CALL | $1,200.00 | 933 | +445 | +91.19% |
| 02/06/2026 | CALL | $1,100.00 | 1,542 | +415 | +36.82% |
| 02/20/2026 | CALL | $1,080.00 | 838 | +343 | +69.29% |
| 02/06/2026 | PUT | $950.00 | 858 | +279 | +48.19% |
| 06/18/2026 | PUT | $900.00 | 652 | +263 | +67.61% |
| 03/20/2026 | CALL | $1,100.00 | 1,894 | -151 | -7.38% |
| 02/20/2026 | CALL | $1,070.00 | 579 | -170 | -22.70% |
| 02/06/2026 | CALL | $1,200.00 | 1,121 | -190 | -14.49% |
| 02/20/2026 | CALL | $1,130.00 | 692 | -321 | -31.69% |
| 06/17/2027 | CALL | $1,300.00 | 429 | -669 | -60.93% |
| 06/17/2027 | CALL | $900.00 | 413 | -670 | -61.87% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
02/07 10:30 pm
The Motley Fool
Read more3 Things Investors Need to Know About the Healthcare Sector in 2026
02/07 10:13 am
The Motley Fool
Read moreEli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore
02/06 03:15 pm
The Motley Fool
Read moreCVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder
02/06 02:52 pm
Benzinga
Read moreAnti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
02/06 06:00 am
GlobeNewswire Inc.
Read moreAmazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
02/05 09:15 pm
The Motley Fool
Read moreEli Lilly's 2026 Outlook Push Back Demand Fears: Analyst
02/05 02:44 pm
Benzinga
Read moreEli Lilly: Why Investors Are Rewarding It as Novo Slips
02/05 11:38 am
Investing.com
Read moreObesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally
02/05 05:00 am
GlobeNewswire Inc.
Read moreWhy Eli Lilly Stock Soared Today
02/04 11:18 pm
The Motley Fool
Read moreNovo Nordisk Faces a Reality Check as Pricing Pressure Hits 2026 Forecasts
02/04 03:22 pm
Investing.com
Read moreIn Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk
02/04 03:02 pm
Benzinga
Read moreQ4 Earnings Summary: Eli Lilly and AbbVie Beat, Uber Mixed
02/04 12:01 pm
Investing.com
Read moreStock Market Today: Dow Futures Gain, Nasdaq Drops As Trump Signs Bill To End Partial Shutdown— AMD, SMCI, LLY In Focus (UPDATED)
02/04 09:53 am
Benzinga
Read moreFDA Moves To Bring Pharma Manufacturing Back To US With New Pilot
02/02 02:11 pm
Benzinga
Read more3 Headwinds Facing Pfizer in 2026
02/02 07:32 am
The Motley Fool
Read moreDemand for Novo Nordisk's Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally?
01/30 07:24 pm
The Motley Fool
Read moreNovo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases
01/30 01:57 pm
Benzinga
Read moreShould You Buy Eli Lilly Before Feb. 4?
01/30 08:15 am
The Motley Fool
Read moreEli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 Billion
01/29 02:58 pm
Benzinga
Read morePrediction: Artificial Intelligence (AI) Will Reshape This Industry by 2030. This Stock Could Lead.
01/29 09:05 am
The Motley Fool
Read moreCan This Beaten-Down AI Stock Bounce Back in 2026?
01/28 10:01 pm
The Motley Fool
Read moreMissed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.
01/28 09:30 pm
The Motley Fool
Read moreNVIDIA Sets Conference Call for Fourth-Quarter Financial Results
01/28 06:00 pm
GlobeNewswire Inc.
Read moreChronic and Acute Pain Clinical Trial Pipeline Analysis: 150+ Key Companies Shaping the Future of Chronic and Acute Pain Therapeutics | DelveInsight
01/28 02:00 pm
GlobeNewswire Inc.
Read moreSeamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss
01/28 08:00 am
GlobeNewswire Inc.
Read moreMedicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
01/28 06:51 am
Benzinga
Read more1 Biotech Stock Set to Rebound in 2026
01/28 02:30 am
The Motley Fool
Read moreAtopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
01/27 11:00 am
GlobeNewswire Inc.
Read moreWhere Will Eli Lilly Be in 10 Years?
01/27 10:07 am
The Motley Fool
Read moreRoche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight
01/27 07:21 am
Benzinga
Read more3 Growth Stocks to Invest $1,000 in Right Now
01/24 09:15 pm
The Motley Fool
Read moreWeight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It
01/23 10:18 am
Benzinga
Read moreEli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026
01/23 06:10 am
The Motley Fool
Read morePostpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider
01/22 12:00 pm
GlobeNewswire Inc.
Read moreWhat Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?
01/20 04:05 pm
The Motley Fool
Read more3 Biotech Stocks to Keep an Eye on in 2026
01/20 09:41 am
Investing.com
Read moreDown 55%, Should You Buy the Dip on Pfizer?
01/19 04:24 pm
The Motley Fool
Read morePrediction: 2026 Will Be the Year of Eli Lilly
01/19 05:10 am
The Motley Fool
Read moreContinuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica
01/16 01:38 pm
GlobeNewswire Inc.
Read moreFDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)
01/16 09:32 am
Benzinga
Read moreInSilico Lands Drug Discovery Deal After Hong Kong IPO
01/15 07:44 am
Benzinga
Read moreDigbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs
01/15 04:26 am
GlobeNewswire Inc.
Read moreEli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief
01/14 03:15 pm
The Motley Fool
Read moreWhy Eli Lilly Stock Gained 39.2% In 2025
01/14 02:13 pm
The Motley Fool
Read more